Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mika Maezawa

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Cureus|March 10, 2025
Analysis of Bevacizumab-Induced Gastrointestinal Perforation Using the Japanese Adverse Drug Event Report DatabaseKana Sugishita, Mika Maezawa, Koumi Miyasaka, et al.
Biological & Pharmaceutical Bulletin|July 16, 2025
Seasonal Variations in Drug-Related Erythema Multiforme: A Time Series Analysis Using the JADER DatabaseHideyuki Tanaka, Mika Maezawa, Sakiko Hirofuji, et al.
Heliyon|November 30, 2023
Evaluation of neuroleptic malignant syndrome induced by antipsychotic drugs using spontaneous reporting systemSakiko Hirofuji, Koumi Miyasaka, Mika Maezawa, et al.
BMC Complementary Medicine and Therapies|March 15, 2024
Analysis of drug-induced interstitial lung disease caused by herbal medicine using the Japanese Adverse Drug Event Report databaseKeita Oura, Mizuki Tanaka, Kiyoka Matsumoto, et al.
Journal of Pharmaceutical Policy and Practice|February 23, 2023
Promoting generic drug usage in Japan: correlation between generic drug usage and monthly personal incomeTakaaki Suzuki, Mari Iwata, Mika Maezawa, et al.
International Journal of Immunopathology and Pharmacology|April 10, 2025
Pharmacovigilance study of immunomodulatory drug-related adverse events using spontaneous reporting system databasesSatoshi Nakao, Mika Maezawa, Moe Yamashita, et al.
SAGE Open Medicine|June 26, 2025
Analysis of adverse events with ruxolitinib using real-world datasets and drug-interaction networksHideyuki Tanaka, Mika Maezawa, Mizuki Tanaka, et al.
Biological & Pharmaceutical Bulletin|September 3, 2025
Seasonal Variation in Diuretic-Induced Dehydration Using Spontaneous Reports of Adverse EventsSatoshi Nakao, Mika Maezawa, Kohei Shiota, et al.
Cureus|February 4, 2025
Self-Organizing Map-Based Assessment of Immune-Related Adverse Events Caused by Immune Checkpoint InhibitorsSatoshi Nakao, Koumi Miyasaka, Mika Maezawa, et al.
Scientific Reports|December 3, 2024
A retrospective study of seasonal variation in sodium-glucose co-transporter 2 inhibitor-related adverse events using the Japanese adverse drug event report databaseKiyoka Matsumoto, Fumiya Goto, Mika Maezawa, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Cureus|March 10, 2025
Analysis of Bevacizumab-Induced Gastrointestinal Perforation Using the Japanese Adverse Drug Event Report DatabaseKana Sugishita, Mika Maezawa, Koumi Miyasaka, et al.
Biological & Pharmaceutical Bulletin|July 16, 2025
Seasonal Variations in Drug-Related Erythema Multiforme: A Time Series Analysis Using the JADER DatabaseHideyuki Tanaka, Mika Maezawa, Sakiko Hirofuji, et al.
Heliyon|November 30, 2023
Evaluation of neuroleptic malignant syndrome induced by antipsychotic drugs using spontaneous reporting systemSakiko Hirofuji, Koumi Miyasaka, Mika Maezawa, et al.
BMC Complementary Medicine and Therapies|March 15, 2024
Analysis of drug-induced interstitial lung disease caused by herbal medicine using the Japanese Adverse Drug Event Report databaseKeita Oura, Mizuki Tanaka, Kiyoka Matsumoto, et al.
Journal of Pharmaceutical Policy and Practice|February 23, 2023
Promoting generic drug usage in Japan: correlation between generic drug usage and monthly personal incomeTakaaki Suzuki, Mari Iwata, Mika Maezawa, et al.
International Journal of Immunopathology and Pharmacology|April 10, 2025
Pharmacovigilance study of immunomodulatory drug-related adverse events using spontaneous reporting system databasesSatoshi Nakao, Mika Maezawa, Moe Yamashita, et al.
SAGE Open Medicine|June 26, 2025
Analysis of adverse events with ruxolitinib using real-world datasets and drug-interaction networksHideyuki Tanaka, Mika Maezawa, Mizuki Tanaka, et al.
Biological & Pharmaceutical Bulletin|September 3, 2025
Seasonal Variation in Diuretic-Induced Dehydration Using Spontaneous Reports of Adverse EventsSatoshi Nakao, Mika Maezawa, Kohei Shiota, et al.
Cureus|February 4, 2025
Self-Organizing Map-Based Assessment of Immune-Related Adverse Events Caused by Immune Checkpoint InhibitorsSatoshi Nakao, Koumi Miyasaka, Mika Maezawa, et al.
Scientific Reports|December 3, 2024
A retrospective study of seasonal variation in sodium-glucose co-transporter 2 inhibitor-related adverse events using the Japanese adverse drug event report databaseKiyoka Matsumoto, Fumiya Goto, Mika Maezawa, et al.
Pageof 3